MAPK3 and type 2 diabetes mellitus: Some researchers established a Type 2 Diabetes Mellitus model for colorectal cancer, and revealed that the activation of ERK1/2 and JNK signaling by insulin and IGF-1, at least in part, is responsible for the development of colon cancer with T2DM (Teng et al., 2016).